Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

Journal of the National Cancer Institute

Volumn 90, Issue 13, 1998, Pages 978-985

  Abbott, Derek W ^a   Freeman, Michael L ^a   Holt, Jeffrey T ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; DEOXYRIBONUCLEOTIDE; DOUBLE STRANDED DNA; ETOPOSIDE; MITOXANTRONE;

ARTICLE; BLASTOCYST; CANCER CELL; CANCER GENETICS; CANCER SUSCEPTIBILITY; CELL DAMAGE; CELL DIFFERENTIATION; CYTOTOXICITY; DNA REPAIR; DNA STRAND BREAKAGE; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; IONIZING RADIATION; PANCREAS ADENOCARCINOMA; RADIOSENSITIVITY;

EID: 0032126029     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.13.978     Document Type: Article

References (26)

1. Livingston, DM. Genetics is coming to oncology. JAMA 1997;277:1476-7.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S. Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
3. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Gen 1996;12:333-7.
4. Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, et al. Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 1996;13:241-4.
5. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-4.
6. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997;386:804-10.
7. Mizuta R, LaSalle JM, Cheng HL, Shinohara A, Ogawa H, Copeland N, et al. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc Natl Acad Sci U S A 1997;94:6927-32.
8. Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S. Grigorieva E, et al. Tumorigenesis and a DNA repair detect in mice with a truncating Brca 2 mutation. Nat Genet 1997;17:423-30.
9. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997;386:761, 763.
10. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996;13:126-8.
11. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995;9:444-50.
12. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phy 1985;11:1699-707.
13. Metzger L, Iliakis G. Kinetics of DNA double-strand break repair throughout the cell cycle as assayed by pulsed field gel electrophoresis in CHO cells. Int J Radiat Biol 1991;59:1325-39.
14. Nevaldine B, Longo JA, Hahn PJ. The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiat Res 1997;147:535-40.
15. Abbott DW, Holt JT. Finkel-Biskis-Reilly mouse osteosarcoma virus v-fos inhibits the cellular response to ionizing radiation in a myristoylation-dependent manner. J Biol Chem 1997;272:14005-8.
16. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-30.
17. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994;54:3025-33.
18. Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, et al. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4) in human ovarian cancer cell lines. Exp Cell Res 1997;233:233-9.
19. Yaginuma Y, Westphal H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res 1992;52:4196-9.
20. Hardman JG, Limbird LE. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw Hill, 1996.
21. Deschavanne PJ, Debieu D, Fertil B, Malaise EP. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins [published erratum appears in Int J Radiat Biol 1986;50:1129]. Int J Radiat Biol 1986;50:279-93.
22. Budach W, Budach V, Stuschke M, Dinges S, Sack H. The TCD50 and regrowth delay assay in human tumor xenografts: differences and implications. Int J Raditat Oncol Biol Phys 1993;25:259-68.
23. Huang P, Allam A, Perez LA, Taghian A, Freeman J, Suit HD. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice. Int J Radiat Oncol Biol Phys 1995;32:93-8.
24. Huang P, Taghian A, Allam A, Freeman J, Duffy M, Suit H. The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograph. Radiat Res 1996;145:337-42.
25. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, et al. Involvement of Brca2 in DNA repair. Molecular Cell 1998;1:347-57.
26. Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZD, Lee WH. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci U S A 1998;95:5287-92.